GSK poaches New Drug-dev chief from Boehringer, dividing R&D into 2 groups
19 Sep 2018 //
ENDPTS
After patient deaths, failed partnerships & scandal, Hanmi gives up olmutinib
14 Apr 2018 //
ENDPTS
Hanmi Pharma gives up on development of lung cancer drug Olita
12 Apr 2018 //
KOREAHERALD